Alembic Pharma gets nod to raise Rs 300 crore via NCDs

12 Jun 2019 Evaluate

Alembic Pharmaceuticals’ board has approved the issue of Unsecured Listed Rated Redeemable Non-Convertible Debentures (NCDs) of upto Rs 300 crore on private placement basis in one or more tranches. The Board of directors of the company at its meeting held on June 12, 2019 has approved for the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×